Santen Pharmaceutical Co., Ltd. (TYO:4536)
2,056.00
-7.00 (-0.34%)
Nov 18, 2026, 3:30 PM JST
Santen Pharmaceutical Market Cap
Santen Pharmaceutical has a market cap or net worth of 661.58 billion as of November 18, 2026. It is the 4,011th most valuable company in the world and the 284th biggest in Japan. Its market cap has increased by 29.17% in one year.
Market Cap
661.58B
Enterprise Value
578.97B
Revenue
297.03B
Global Rank
Country Rank
#284 Japan
PE Ratio
17.04
ChartMarket Cap Chart
Since January 14, 1992, Santen Pharmaceutical's market cap has increased from 150.82B to 661.58B, an increase of 338.66%. That is a compound annual growth rate of 4.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 661.58B | 26.51% |
| Dec 30, 2025 | 522.95B | -5.35% |
| Dec 30, 2024 | 552.48B | 8.00% |
| Dec 29, 2023 | 511.57B | 23.49% |
| Dec 30, 2022 | 414.25B | -26.39% |
| Dec 30, 2021 | 562.77B | -15.93% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 12.31T |
| Takeda Pharmaceutical Company | 11.23T |
| HOYA Corporation | 7.78T |
| Otsuka Holdings | 6.68T |
| Sumitomo Pharma | 900.55B |
| MediPal Holdings | 674.48B |
| Sugi Holdings | 537.98B |
| COSMOS Pharmaceutical | 524.52B |